Skip to content
OpenCapital
Get started

Perspective Therapeutics CATX Current ratio

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
10.4×+8.7×
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
56×—
Immunome logo
ImmunomeIMNM
21.7×+11.2×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
15.1×-4.3×
Lantheus Holdings logo
Lantheus HoldingsLNTH
2.8×-2.9×

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%—

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0×0.0×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

total current assets/total current liabilities=8.7×

Based on the most recent quarter.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's current ratio?
Perspective Therapeutics (CATX) reported current ratio of 8.7× in Q1 2026.
How has Perspective Therapeutics's current ratio changed year-over-year?
Perspective Therapeutics's current ratio decreased by 48.6% year-over-year, from 17× to 8.7×.
What is the long-term trend for Perspective Therapeutics's current ratio?
Over 5 years (2020 to 2025), Perspective Therapeutics's current ratio has grown at a -10.9% compound annual growth rate (CAGR), from 9.2× to 5.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.